FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

725960003: Lapatinib ditosylate monohydrate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3446997013 Lapatinib ditosylate monohydrate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3446998015 Lapatinib ditosylate monohydrate en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lapatinib ditosylate monohydrate Is a Lapatinib ditosylate false Inferred relationship Existential restriction modifier
Lapatinib ditosylate monohydrate Has disposition Protein-tyrosine kinase inhibitor true Inferred relationship Existential restriction modifier
Lapatinib ditosylate monohydrate Is modification of Lapatinib ditosylate true Inferred relationship Existential restriction modifier
Lapatinib ditosylate monohydrate Is a Quinazoline true Inferred relationship Existential restriction modifier
Lapatinib ditosylate monohydrate Is a Substance with protein-tyrosine kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Lapatinib ditosylate monohydrate Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Lapatinib ditosylate monohydrate Is a Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Lapatinib ditosylate monohydrate Has disposition Epidermal growth factor receptor inhibitor true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lapatinib 250mg tablets Has specific active ingredient True Lapatinib ditosylate monohydrate Inferred relationship Existential restriction modifier
Lapatinib 250mg tablets Has specific active ingredient False Lapatinib ditosylate monohydrate Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) Has specific active ingredient True Lapatinib ditosylate monohydrate Inferred relationship Existential restriction modifier
Lapatinib 250mg tablets 70 tablet Has specific active ingredient True Lapatinib ditosylate monohydrate Inferred relationship Existential restriction modifier
Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet Has specific active ingredient False Lapatinib ditosylate monohydrate Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets Has specific active ingredient True Lapatinib ditosylate monohydrate Inferred relationship Existential restriction modifier
Lapatinib 250mg tablets 84 tablet Has specific active ingredient True Lapatinib ditosylate monohydrate Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets Has specific active ingredient True Lapatinib ditosylate monohydrate Inferred relationship Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet Has specific active ingredient True Lapatinib ditosylate monohydrate Inferred relationship Existential restriction modifier
Lapatinib 250mg tablets 105 tablet Has specific active ingredient True Lapatinib ditosylate monohydrate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start